ITGAM and colorectal carcinoma: To verify the immunosuppressive role of these CD11b+CD16−myeloid cells, we sorted peripheral blood CD11b+CD16−myeloid cells from capecitabine-resistant CRC patients, and CD11b+CD16+myeloid cells from capecitabine-sensitive CRC patients or HDs, and autologous T cells as well.